Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
yes
Remarks:
starting dose was 200 mg/kg
Principles of method if other than guideline:
References for test guidelines given in the study report:
EEC Directive 92/69, Publication No. L383A, B.1: Acute Toxicity-oral, December 29, 1992;
Acute toxic class method, A national validation study of the ATC Method - an alternative to the LD50 test, Arch. Toxicol. 66: 455-470, 1992
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method

Test material

Constituent 1
Chemical structure
Reference substance name:
1-(4-chlorophenyl)pyrazol-3-ol
EC Number:
616-307-3
Cas Number:
76205-19-1
Molecular formula:
C9 H7 Cl N2 O
IUPAC Name:
1-(4-chlorophenyl)pyrazol-3-ol
Specific details on test material used for the study:
- Name of test material (as cited in study report): pyrazolon
- Physical state: crystalline powder, light-beige
- Analytical purity/Content: 100.5 g/ 100 g (H-NMR and IR spectroscopy)
- Lot/batch No.: 27967/95
- Storage condition of test material: room temperature, exclusion of light

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach, Federal Republic of Germany
- Age at study initiation: young adults
- Weight at study initiation: animals of comparable weight; 150-300g (+/- 20% of the mean weight)
- Fasting period before study: at least 16 hours before administration
- Housing: single housing, stainless steel wire mesh cages
- Diet (e.g. ad libitum): ad libitum (Kliba labor diet 343, assayed for chemical and microbiological contaminants)
- Water (e.g. ad libitum): ad libitum (tap water, regularly assayed for chemical contaminants)
- Acclimation period: at least 1 week


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C (no deviations from these ranges which influenced the results of the study)
- Humidity (%): 30 - 70% (no deviations from these ranges which influenced the results of the study)
- Photoperiod (hrs dark / hrs light): 12/12


Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
VEHICLE
(cleaned natriumcarboxymethylcellulose in aqua bidest.)
- Concentration in vehicle: 2 g/100 ml and 20 g/100 ml
- Amount of vehicle (if gavage): 10 ml/kg

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: based on the physical and chemical characteristics of the test substance
Doses:
200 and 2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
clinical signs and symptoms: several times on the day of administration, at least once each workday;
mortality: twice each workday and once on Saturdays and Sundays;
body weights: d0 (shortly before application), weekly thereafter and at the end of the study (before fasting period)
- Necropsy of survivors performed: yes (withdrawl of food at least 16 hours before killing with CO2)

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
No mortalities occured
Clinical signs:
other: 200 mg/kg: no symptoms observed in males and females 2000 mg/kg: all males showed an impaired or poor general state, dyspnoea, staggering and piloerection, 2/3 males showed apathy; in female animals no abnormalities were observed
Gross pathology:
No findings

Applicant's summary and conclusion